Consensus DexCom, Inc. Mexican S.E.

Stocks

DXCM *

US2521311074

Medical Equipment, Supplies & Distribution

End-of-day quote Mexican S.E. 22/09/2026			5-day change	1st Jan Change
1,536.29 ^MXN	+0.48%		+0.48%	+26.65%

04:21pm	Dexcom Publishes New Report During Easd 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care	CI
03:16pm	Tandem Diabetes Expands Insulin Delivery System to 12 New Countries	MT

fa37.g80-8WQXifFCQXaCJm1byXQ_b9lHVMtkRUjKztWWMx0.26ZpvSMv6JJ6JxXKTBoiiiJWMJgyAKULDBCTopffCij5oU3cNGa8nwEOMw~066c5984a9eee24af13bc495194d96aa

Analysts' recommendations: DexCom, Inc.

17/09	Truist Securities Adjusts DexCom Price Target to $102 From $93, Maintains Buy Rating	MT
13/08	Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating	MT
04/08	Argus Adjusts Price Target on DexCom to $96 From $86, Maintains Buy Rating	MT
03/08	UBS Adjusts Price Target on DexCom to $102 From $96, Maintains Buy Rating	MT
03/08	Rothschild & Co Redburn Adjusts Price Target on DexCom to $100 From $90, Maintains Buy Rating	MT
31/07	DexCom Glucose Monitors' National Coverage Could Support H2 Upside, RBC Capital Markets Says	MT
31/07	Leerink Partners Adjusts Price Target on DexCom to $94 From $80, Maintains Outperform Rating	MT
31/07	RBC Raises Price Target on DexCom to $90 From $85, Keeps Outperform Rating	MT
31/07	Canaccord Genuity Adjusts Price Target on DexCom to $90 From $82, Maintains Buy Rating	MT
31/07	Evercore ISI Adjusts Price Target on DexCom to $100 From $90, Maintains Outperform Rating	MT
31/07	Mizuho Adjusts Price Target on DexCom to $95 From $90, Maintains Outperform Rating	MT
31/07	Benchmark Adjusts Price Target on DexCom to $82 From $77, Maintains Buy Rating	MT
31/07	Bernstein Adjusts Price Target on DexCom to $90 From $77, Maintains Outperform Rating	MT
31/07	Deutsche Bank Adjusts DexCom Price Target to $92 From $86, Maintains Buy Rating	MT
31/07	Truist Raises Price Target on DexCom to $93 From $87, Keeps Buy Rating	MT
31/07	Baird Adjusts Price Target on DexCom to $105 From $80, Maintains Outperform Rating	MT
31/07	JPMorgan Adjusts Price Target on DexCom to $82 From $65, Maintains Neutral Rating	MT
31/07	Piper Sandler Adjusts Price Target on DexCom to $95 From $88, Maintains Overweight Rating	MT
31/07	Wells Fargo Adjusts Price Target on DexCom to $90 From $85, Maintains Overweight Rating	MT
31/07	Stifel Adjusts Price Target on DexCom to $95 From $90, Maintains Buy Rating	MT
31/07	Citigroup Adjusts Price Target on DexCom to $88 From $84, Maintains Buy Rating	MT
31/07	Jefferies Adjusts Price Target on DexCom to $115 From $112, Maintains Buy Rating	MT
31/07	BTIG Adjusts Price Target on DexCom to $90 From $80, Maintains Buy Rating	MT
31/07	Raymond James Adjusts Price Target on DexCom to $94 From $91, Maintains Strong Buy Rating	MT
31/07	Analyst recommendations: Apple, Baxter International, Dexcom, Flex, Humana, Stellantis…

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ABBOTT LABORATORIES					+18.73%
	MEDTRONIC PLC					+18.27%
	CENCORA, INC.					+20.31%
	BECTON, DICKINSON AND COMPANY					+6.44%
	HOYA CORPORATION					+28.59%
	DEXCOM, INC.					+9.07%
	MEDLINE INC.					+28.35%
	WEST PHARMACEUTICAL SERVICES, INC.					+10.02%
	SARTORIUS STEDIM BIOTECH					+10.88%
	Average					+16.74%
	Weighted average by Cap.					+17.81%